SEC Info - Adaptimmune Therapeutics plc - ‘8-K’ for 4/10/24

SEC Info℠

Home

Help

Please Sign In

Adaptimmune Therapeutics plc – ‘8-K’ for 4/10/24

On: Friday, 4/12/24, at 8:05am ET · For: 4/10/24 · Accession #: 1558370-24-4997 · File #: 1-37368

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/12/24  Adaptimmune Therapeutics plc      8-K:1,9     4/10/24   11:179K                                   Toppan Merrill Bridge/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     40K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     12K 
 6: R1          Document and Entity Information                     HTML     47K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
11: XML         XBRL Instance -- adap-20240410x8k_htm                XML     16K 
 7: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- adap-20240410_lab                     XML     46K 
 5: EX-101.PRE  XBRL Presentations -- adap-20240410_pre              XML     32K 
 3: EX-101.SCH  XBRL Schema -- adap-20240410                         XSD     14K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    17K 
10: ZIP         XBRL Zipped Folder -- 0001558370-24-004997-xbrl      Zip     17K

Filing Submission 0001558370-24-004997 – SGML Text

Original SGML Text submitted by:	Toppan Merrill Bridge/FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 179K ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20240412-080621	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20240412-080619	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20240412-080549	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001558370-24-004997
<TYPE>				8-K
<PUBLIC-DOCUMENT-COUNT>		15
<PERIOD>			20240410
<ITEMS>				1.02
<ITEMS>				9.01
<FILING-DATE>			20240412
<DATE-OF-FILING-DATE-CHANGE>	20240412

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		Adaptimmune Therapeutics PLC
<CIK>				0001621227
<ASSIGNED-SIC>			2836
<ORGANIZATION-NAME>		03 Life Sciences
<IRS-NUMBER>			000000000
<STATE-OF-INCORPORATION>	X0  ⇐ This is an SEC Country/Territory Code for
				United Kingdom {GB|GBR}
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			8-K
<ACT>				34
<FILE-NUMBER>			001-37368
<FILM-NUMBER>			24840030
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			60 JUBILEE AVENUE
<STREET2>			MILTON PARK
<CITY>				ABINGDON, OXFORDSHIRE
<STATE>				X0  ⇐ This is an SEC Country/Territory Code for
				United Kingdom {GB|GBR}
<ZIP>				OX14 4RX
<PHONE>				44 1235 430000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			60 JUBILEE AVENUE
<STREET2>			MILTON PARK
<CITY>				ABINGDON, OXFORDSHIRE
<STATE>				X0  ⇐ This is an SEC Country/Territory Code for
				United Kingdom {GB|GBR}
<ZIP>				OX14 4RX
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		Adaptimmune Ltd
<DATE-CHANGED>			20141001
</FORMER-COMPANY>
</FILER>

<DOCUMENT>
<TYPE>		8-K
<SEQUENCE>	1
<FILENAME>	adap-20240410x8k.htm
<DESCRIPTION>	8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
       Show <XBRL>: 12 lines (widest: 22,626 characters) - 40K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-99.1
<SEQUENCE>	2
<FILENAME>	adap-20240410xex99d1.htm
<DESCRIPTION>	EX-99.1
<TEXT>
       Show <TEXT>: 1 lines (widest: 8,614 characters) - 9K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	3  ⇐ Not a Document/Exhibit
<FILENAME>	adap-20240410xex99d1001.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 122 lines (Unix-to-Unix encoding) - 8K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	4  ⇐ Not a Document/Exhibit
<FILENAME>	adap-20240410xex99d1002.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 84 lines (Unix-to-Unix encoding) - 5K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.SCH
<SEQUENCE>	5  ⇐ Document/Exhibit 3
<FILENAME>	adap-20240410.xsd
<DESCRIPTION>	EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
       Show <XBRL>: 25 lines (widest: 1,619 characters) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.LAB
<SEQUENCE>	6  ⇐ Document/Exhibit 4
<FILENAME>	adap-20240410_lab.xml
<DESCRIPTION>	EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
       Show <XBRL>: 83 lines (widest: 311 characters) - 16K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.PRE
<SEQUENCE>	7  ⇐ Document/Exhibit 5
<FILENAME>	adap-20240410_pre.xml
<DESCRIPTION>	EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
       Show <XBRL>: 59 lines (widest: 316 characters) - 11K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	9  ⇒ 8  ⇐ Document/Exhibit 6
<FILENAME>	R1.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 837 lines (widest: 387 characters) - 39K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EXCEL
<SEQUENCE>	10  ⇒ 9  ⇐ Document/Exhibit 7
<FILENAME>	Financial_Report.xlsx
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 132 lines (Unix-to-Unix encoding) - 8K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	11  ⇒ 10  ⇐ Not a Document/Exhibit
<FILENAME>	Show.js
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 5 lines (widest: 296 characters) - 973 bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	12  ⇒ 11  ⇐ Not a Document/Exhibit
<FILENAME>	report.css
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 182 lines (widest: 57 characters) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	14  ⇒ 12  ⇐ Document/Exhibit 8
<FILENAME>	FilingSummary.xml
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
       Show <XML>: 48 lines (widest: 100 characters) - 2K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		JSON
<SEQUENCE>	16  ⇒ 13  ⇐ Document/Exhibit 9
<FILENAME>	MetaLinks.json
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 591 lines (widest: 315 characters) - 17K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		ZIP
<SEQUENCE>	17  ⇒ 14  ⇐ Document/Exhibit 10
<FILENAME>	0001558370-24-004997-xbrl.zip
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 285 lines (Unix-to-Unix encoding) - 18K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	19  ⇒ 15  ⇐ Document/Exhibit 11
<FILENAME>	adap-20240410x8k_htm.xml
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
       Show <XML>: 88 lines (widest: 160 characters) - 5K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0001558370-24-004997 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Adaptimmune Therapeutics plc – ‘8-K’ for 4/10/24

On: Friday, 4/12/24, at 8:05am ET · For: 4/10/24 · Accession #: 1558370-24-4997 · File #: 1-37368

Previous ‘8-K’: ‘8-K’ on / for 3/6/24 · Next: ‘8-K’ on / for 5/14/24 · Latest: ‘8-K’ on / for 5/15/24 · 1 Reference: To: Adaptimmune Therapeutics plc – ‘10-Q’ on 11/4/21 for 9/30/21

Current Report — Form 8-KFiling Table of Contents

Current Report — Form 8-K

Filing Table of Contents